Kevin Robb
Kevin Robb is a scientist interested in mesenchymal stromal cells, cell therapy, and translational research. He holds a PhD in Biomedical Engineering from the University of Toronto, a Master of Engineering Science from Western University, and a Bachelor of Science, Honours Physiology from McGill University. Kevin is passionate about scientific discovery, regenerative medicine, and science communication. You can connect and follow Kevin's updates on LinkedIn (https://www.linkedin.com/in/robbk/).
Posts by: Kevin
Mesenchymal stromal cell product joins FDA’s list of approved cell and gene therapies
For the first time, mesenchymal stromal cells (MSCs) can be used in routine clinical practice under the nod of regulatory approval in the United States. The MSC product known as Ryoncil was made available to patients in March 2025 following a historic decision from the U.S. Food & Drug Administration (FDA) to approve its first […]
A bench-to-bedside story of BlueRock’s investigational stem cell therapy for Parkinson’s disease
BlueRock Therapeutics has generated considerable media buzz with their announcement of positive Phase I clinical trial data on bemdaneprocel (BRT-DA01), an investigational, stem cell-derived, dopaminergic therapy for Parkinson’s disease. The trial is the result of decades of research and investments that yielded this exciting step into clinical translation. Founded in 2016 by Versant Ventures and […]
Mesenchymal stromal cell snapshot: are new therapies on the horizon?
Mesenchymal stromal cells (MSCs) have been at the front line of cell therapy and regenerative medicine efforts for decades. Investigators hotly pursued MSCs as prospective cell therapies for a wide range of diseases, but enthusiasts were left wanting when several large clinical trials failed to meet their efficacy endpoints. While the MSC field may have […]
The PhD afterlife: Evaluating the postdoc as a next step
It was a strange feeling, completing my PhD defense. After immersing myself for years in a highly specific research area, the months leading up to my defense felt like a storm rolling in: my mind became increasingly clouded with technical details, emerging concepts in the field, and new hypotheses. And then in a flash, the […]